Harmony Biosciences Q4 Adj. EPS $0.57 Misses $0.90 Estimate, Sales $243.776M Beat $240.286M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsEarnings MissesNews
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.90 by 36.74 percent. This is a 48.18 percent decrease over earnings of $1.10 per share
Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.90 by 36.74 percent. This is a 48.18 percent decrease over earnings of $1.10 per share from the same period last year. The company reported quarterly sales of $243.776 million which beat the analyst consensus estimate of $240.286 million by 1.45 percent. This is a 21.12 percent increase over sales of $201.267 million the same period last year.